Bruce L. A. Carter, Director at Mirati Therapeutics, Inc. (MRTX), sold 4,450 shares at $248.28 ($1.1M) on 2020-12-14, disclosed to the SEC on 2020-12-16.
Open-market sale of $1.1M MRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $240.93 | 49 | $12K | 1.1% |
| 2 | $244.05 | 287 | $70K | 6.4% |
| 3 | $244.05 | 287 | $70K | 6.4% |
| 4 | $244.97 | 589 | $144K | 13.2% |
| 5 | $244.97 | 589 | $144K | 13.2% |
| 6 | $246.27 | 257 |
| $63K |
| 5.8% |
| 7 | $246.27 | 257 | $63K | 5.8% |
| 8 | $247.63 | 710 | $176K | 16.0% |
| 9 | $247.63 | 710 | $176K | 16.0% |
| 10 | $248.28 | 357 | $89K | 8.1% |
| 11 | $248.28 | 357 | $89K | 8.1% |
| 12 | $248.96 | 1 | $249 | 0.0% |
| Total | $246.34 avg | 4,450 | $1.1M | 100% |
| Filing → |
| MRTX | SELL | 2021-04-06 | $746K | — | Filing → |
| MRTX | SELL | 2021-02-03 | $430K | — | Filing → |
| MRTX | SELL | 2020-08-13 | $378K | — | Filing → |